1. Pericardial Effusion in Children Admitted With Kawasaki Disease: A Multicenter Retrospective Cohort Study From the Pediatric Health Information System
- Author
-
R. Thomas Collins, Stephen M. Schexnayder, Elijah H. Bolin, Xinyu Tang, and Amy G. Schexnayder
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Pediatric health ,Length of hospitalization ,Comorbidity ,Mucocutaneous Lymph Node Syndrome ,030204 cardiovascular system & hematology ,Patient Readmission ,Pericardial effusion ,Pericardial Effusion ,Cohort Studies ,Health Information Systems ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,030212 general & internal medicine ,Retrospective Studies ,Delayed discharge ,business.industry ,Retrospective cohort study ,Odds ratio ,Length of Stay ,medicine.disease ,United States ,Black or African American ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Cohort ,Female ,Kawasaki disease ,business - Abstract
Pericardial effusion (PCE) can be associated with Kawasaki disease (KD). We performed a multicenter, retrospective cohort study of the Pediatric Health Information System of children admitted with KD to determine the association between PCE and adverse outcomes. A total of 17 422 patients were in the cohort, of which 440 (3%) had PCE. PCE was associated with longer hospital length of stay (adjusted odds ratio [aOR] = 1.23; P < .01) and risk of readmission at 30 days (aOR = 1.42; P = .03). Black children were more likely to have a PCE (aOR = 1.54, P < .01) and longer length of stay (aOR = 1.05; P < .001). These data may support delayed discharge in children with PCE and KD in the hopes of preventing readmission. Special consideration needs to be given to how black children with KD are managed.
- Published
- 2020
- Full Text
- View/download PDF